Overview

Antimicrobial Therapy for Ulcerative Colitis (UC)

Status:
Recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
The Aim of this randoized controlled pilot study is to find a better treatment strategy for active UC based on the recent knowledge regarding the microbiota in UC and the beneficial or detrimental effects of antibiotics in restoring gut health and reducing inflammation. This study is designed to determine whether therapy with two antibiotics during a flare - amoxicillin and doxycillin, will be better than the current published antibiotic treatment combination using these antibiotics with metronidazole ( as the latter which may degrade beneficial species without adding benefit towards reducing pathobionts)
Phase:
Phase 2
Details
Lead Sponsor:
Wolfson Medical Center
Treatments:
Amoxicillin
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Doxycycline
Metronidazole
Tetracycline